PlayOn11 - Where Fans Become Winners
FDA Approves Merck’s Once-Daily IDVYNSO™ (doravirine/islatravir)

IDVYNSO is approved for adults with virologically suppressed HIV-1 with no history of virologic trea...

LATEST NEWS April 21, 2026

FDA Approves Merck’s Once-Daily IDVYNSO™ (doravirine/islatravir)

IDVYNSO is approved for adults with virologically suppressed HIV-1 with no history of virologic treatment failure and no known substitutions associated with...

1 views 0 likes 0 comments
IDVYNSO is approved for adults with virologically suppressed HIV-1 with no history of virologic treatment failure and no known substitutions associated with...

Author: Merck.com

Read Original Article

Related News

Top Categories